We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter
Est. Return
+40.87%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$23.6M
(+30%)
Cap. Flow
+$708K
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
41.2%
Holding
109
New
6
Increased
19
Reduced
18
Closed
6
Avg Time Held
3.9
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vicor
VICR
|
+$505K |
| 2 |
Azenta
AZTA
|
+$498K |
| 3 |
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
|
+$434K |
| 4 |
USA Compression Partners
USAC
|
+$374K |
| 5 |
INVE Technologies, Inc. Common Stock
INVE
|
+$261K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CryoPort
CYRX
|
+$631K |
| 2 |
CYBE
Cyberoptics Corp
CYBE
|
+$575K |
| 3 |
AGN
Allergan plc
AGN
|
+$511K |
| 4 |
Fidelity National Information Services
FIS
|
+$234K |
| 5 |
Axcelis
ACLS
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.83% |
| 2 | Healthcare | 17.53% |
| 3 | Financials | 10.01% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Abbott
ABT
$181B
| $351K | 0.35% |
3,840
| – | – |
2017 Q4
10 quarters
|
|
|
NYV
77
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
| $341K | 0.34% |
25,000
| – | – |
2013 Q4
26 quarters
|
|
78
Barrett Business Services
BBSI
$788M
| $335K | 0.33% |
25,200
| – | – |
2015 Q4
18 quarters
|
|
|
PVG
79
DELISTED
PRETIUM RESOURCES INC.
PVG
| $318K | 0.31% |
37,900
| – | – |
2016 Q2
16 quarters
|
|
|
BMCH
80
DELISTED
BMC Stock Holdings, Inc
BMCH
| $317K | 0.31% |
12,600
| – | – |
2015 Q3
19 quarters
|
|
|
LMRK
81
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $315K | 0.31% |
31,830
+1,000
| +3% | +$10.3K |
2015 Q2
20 quarters
|
|
82
Vermilion Energy
VET
$2.02B
| $313K | 0.31% |
70,650
| – | – |
2017 Q4
10 quarters
|
|
|
MIN
83
Aberdeen Intermediate Income Fund
MIN
$269M
| $304K | 0.3% |
13,705
-167
| -1% | -$3.77K |
2013 Q4
26 quarters
|
|
84
Nuveen Municipal Value Fund
NUV
$1.73B
| $270K | 0.27% |
26,500
| – | – |
2019 Q3
3 quarters
|
|
85
John Wiley & Sons Class A
WLY
$2.67B
| $242K | 0.24% |
6,200
| – | – |
2013 Q4
26 quarters
|
|
86
General Mills
GIS
$17.7B
| $237K | 0.23% |
3,840
| – | – |
2019 Q2
4 quarters
|
|
87
GrafTech
EAF
$186M
| $231K | 0.23% |
2,890
| – | – |
2018 Q3
7 quarters
|
|
88
Sinclair Inc
SBGI
$907M
| $227K | 0.22% |
12,300
| – | – |
2018 Q2
8 quarters
|
|
89
Beeline Holdings
BLNE
$25.6M
| $226K | 0.22% |
780
| – | – |
2019 Q3
3 quarters
|
|
90
The GEO Group
GEO
$3.77B
| $224K | 0.22% |
18,950
+800
| +4% | +$9.77K |
2015 Q3
19 quarters
|
|
91
Global Partners
GLP
$1.68B
| $216K | 0.21% |
22,080
| – | – |
2013 Q4
26 quarters
|
|
|
BAF
92
DELISTED
BLACKROCK MUNICIPAL INCOME INVESTMENT QUALITY TRUST
BAF
| $204K | 0.2% |
15,000
| – | – |
2019 Q3
3 quarters
|
|
93
The ONE Group
STKS
$38.3M
| $159K | 0.16% |
97,705
| – | – |
2018 Q3
7 quarters
|
|
94
Ares Capital
ARCC
$13.4B
| $154K | 0.15% |
+10,640
| New | +$144K |
2020 Q2
0 quarters
|
|
|
CSLT
95
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $80K | 0.08% |
96,750
| – | – |
2018 Q2
8 quarters
|
|
96
Antero Midstream
AM
$9.8B
| $51K | 0.05% |
+10,000
| New | +$44.3K |
2020 Q2
0 quarters
|
|
|
MMX
97
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $44K | 0.04% |
10,000
| – | – |
2019 Q4
2 quarters
|
|
|
ABMC
98
DELISTED
AMERICAN BIO MEDICA CORP
ABMC
| $44K | 0.04% |
+41,500
| New | +$44K |
2020 Q2
0 quarters
|
|
99
abrdn Asia-Pacific Income Fund
FAX
$530M
| $40K | 0.04% |
1,767
| – | – |
2013 Q4
26 quarters
|
|
100
DELISTED
DallasNews
DALN
| $39K | 0.04% |
5,669
| – | – |
2016 Q2
16 quarters
|
|
Similar funds
ACA
CCM
CIA
EG
ANHIM
WS
CBOR
NWMG
Penbrook Management's Q2 2020 Portfolio in Review
As of Q2 2020, Penbrook Management held 109 positions worth $102M, up 30% from $78.1M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Penbrook Management's Q2 2020 filing shows 6 new, 19 increased, 18 reduced and 6 closed positions. Its largest new stake was Vicor: 9,000 shares worth $648K. The largest sale was CryoPort, an estimated $631K.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Penbrook Management's largest Q2 2020 buy was Vicor: 9,000 shares worth $648K.
- Penbrook Management added most to Azenta in Q2 2020, an estimated $498K increase.
- Penbrook Management's biggest Q2 2020 reduction was CryoPort, cutting an estimated $631K.
- Penbrook Management fully exited Allergan plc in Q2 2020, selling an estimated $511K.
- Penbrook Management's ten largest holdings make up 41% of its $102M portfolio in Q2 2020.
- Penbrook Management opened 6 new positions and closed 6 in Q2 2020.
- Penbrook Management's portfolio value rose 30% quarter-over-quarter to $102M.
Based on Penbrook Management's 13F filing for Q2 2020, filed 28 Jul 2020.